Grace Ross20 said:Hey everyone, just wanted to check in. Dad is still holding steady; he’s picking up new words every day now and is actually lifting his right arm and leg.
He’s handling the treatment well, though I’m trying not to get ahead of myself with too much excitement—radiation side effects usually don't show their face until later on.
Contina, how is your husband doing? Any news?
I’m heading to a lecture on clinical trials next week, so they’ll likely bring up DCVAX; I assume you've already looked into it. Could this be our big break? The trials are pretty advanced, but I have no idea how long it takes to actually become part of a standard protocol.
Back when I was posting in the Glioblastoma thread, I mentioned DCVAX while it was still in the in vivo stage. So, they really have moved into clinical studies... that's great news.
To try and get into a test group, you have to submit an application directly to the clinic running the study and see what their specific candidacy requirements are.
From what I recall, it’s an immunotherapy made from the tumor tissue itself. Now, I can't remember if a patient has to have surgery first or if they can use something from a biopsy... I'm not entirely sure.
I did a quick Google search, and it looks like the only studies currently in the US and Europe are in England and Germany.
The one in Germany isn't recruiting anymore, and looking at their criteria, they require the patient to have had surgery since they need the actual tissue to create the preparation.
https://clinicaltrials.gov/ct2/show/...EU%3ADE&rank=1
Regarding the protocols, the drug has to prove it's more effective than the current standard of care, which requires more randomized studies involving larger groups of people. If everything lines up, the pharma company applies for FDA registration, and then the new protocols are officially introduced.
By the way, there are currently 40 GBM studies actively recruiting.
http://www.clinicaltrials.gov/ct2/re...toma&recr=Open
This website always provides the most reliable data on available studies for all possible diagnoses, along with precise details ranging from how to apply to the specific requirements, obligations, and benefits.